ISUS:LSE:LSE-iShares MSCI USA Islamic UCITS (GBX)

ETF | Others |

Last Closing

USD 5606

Change

0.00 (0.00)%

Market Cap

USD 0.23B

Volume

1.03K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-19 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XNID:LSE Xtrackers Nifty 50 Swap UCITS ..

N/A

USD 292,109.69B
0R1O:LSE Amazon.com Inc.

N/A

USD 1,607.29B
0R1I:LSE NVIDIA Corp.

N/A

USD 618.20B
LCJD:LSE Amundi MSCI Japan (DR) UCITS E..

N/A

USD 510.38B
LCJP:LSE Lyxor Core MSCI Japan (DR) UCI..

N/A

USD 510.38B
0R1G:LSE Home Depot Inc.

N/A

USD 373.16B
0QZK:LSE Coca-Cola Co.

N/A

USD 266.08B
0QZO:LSE 0QZO

N/A

USD 258.54B
PRJU:LSE Amundi Index Solutions - Amund..

N/A

USD 210.67B
0QZ3:LSE Qualcomm Inc.

N/A

USD 202.26B

ETFs Containing ISUS:LSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.92% 40% F 46% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.92% 40% F 47% F
Trailing 12 Months  
Capital Gain 10.89% 34% F 40% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.89% 34% F 41% F
Trailing 5 Years  
Capital Gain 66.87% 75% C 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 66.87% 75% C 75% C
Average Annual (5 Year Horizon)  
Capital Gain 12.40% 73% C 74% C
Dividend Return 12.72% 74% C 74% C
Total Return 0.32% 41% F 49% F
Risk Return Profile  
Volatility (Standard Deviation) 8.16% 75% C 86% B+
Risk Adjusted Return 155.95% 100% F 100% F
Market Capitalization 0.23B 61% D- 35% F

Annual Financials (GBX)

Quarterly Financials (GBX)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.